My ePortfolio Register   

Nivolumab for NSCLC: five years on

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.04.17
Views: 232

Prof Julie Brahmer - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA

Prof Brahmer presents data at AACR 2017 from a five year follow up of patients with non-small cell lung cancer treated with nivolumab.

Prof Brahmer spoke with ecancer about these results here, and slides from this presentation are available here.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence